-
Nov 22, 10 Drug News
Celldex Therapeutics Inc said its experimental vaccine for the most common type of brain cancer met the main goal of… »
Nov 22, 10 Clinical UpdatesKidney disease patients treated with Merck & Co Inc’s cholesterol-lowering drug Vytorin were about 16 percent less likely to have… »
Nov 19, 10 Drug NewsIt’s not often that spontaneous applause erupts halfway through a scientific talk. But when malaria researcher Arjen Dondorp came to… »
Nov 18, 10 Clinical UpdatesWidely prescribed for their cholesterol-lowering properties, recent clinical research indicates that statins can produce a second, significant health benefit:… »
Nov 18, 10 Drug NewsNew research being presented at the 2010 FIP Pharmaceutical Sciences World Congress in association with the American Association of Pharmaceutical… »
Nov 17, 10 Drug NewsA key enzyme in Mycobacterium tuberculosis that enables the microbe to reproduce rapidly could be a golden target for new… »
Nov 17, 10 Clinical UpdatesTargeted cancer therapies such as trastuzumab (Herceptin), gefitinib (Iressa) and erlotinib (Tarceva) could be used to treat a wider range… »
Nov 17, 10 Drug NewsResearchers have developed a promising new approach to vaccination for rotavirus, a common cause of severe diarrheal disease that is… »
Nov 17, 10 Clinical UpdatesFailure to have a prescription filled can undermine medical treatment, result in increased health care costs and potentially have… »
Nov 16, 10 Clinical UpdatesA half dozen experimental stroke-prevention drugs, and one already on the market, are racing for their share of a… »
Subscribe to the "News" RSS Feed
TOP ۞